{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/DRMA",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Dermata Therapeutics, Inc. (NASDAQ: DRMA) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Dermata Therapeutics, Inc., listed on NASDAQ under ticker DRMA, with ISIN US2498455045. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Security type is Corporate, sector is 2834 Pharmaceutical Preparations, and jurisdiction is United States, Delaware. Segment is not on the record. Status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 67 filings across 40 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 5 days, and the latest filing is 6 days before the record date of 2026-11-08. The latest filing is a regulatory filing dated 2026-11-02. Exchange peers on NASDAQ (4,359 issuers) show a median of 52 filings, a median cadence gap of 6.0 days, and a median latency of 5.0 days. Sector peers in 2834 Pharmaceutical Preparations (526 issuers) show a median of 63.0 filings, a median cadence gap of 6.0 days, and a median latency of 4.0 days. The issuer's filing count of 67 is above the exchange median of 52 and above the sector median of 63.0.\n\n## Auditor\n\nThe auditor of record is CBIZ CPAs P.C, located in San Diego, California. The record holds one auditor change, dated 2026-02-03.\n\n## Events and halts\n\nThe record holds one delisting line, dated 2026-08-17. No listing or name change lines are on the record. Domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). Segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page. The count is 0.\n\n## Open research\n\nNo openly published research notes were found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001853816.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/DRMA (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1853816/000149315226012992/form10-k.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/DRMA (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1853816/000149315226012992/form10-k.htm",
    "state": "sourced",
    "value": "CBIZ CPAs P.C"
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1853816/000149315226012992/form10-k.htm",
    "state": "sourced",
    "value": "199"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1853816/000149315226012992/form10-k.htm",
    "state": "sourced",
    "value": "San\nDiego, California"
   },
   "changes": [
    {
     "date": "2026-02-03",
     "source": "https://www.sec.gov/Archives/edgar/data/1853816/000149315226004905/form8-k.htm",
     "title": "8-K — 8-K (items 4.01,9.01)"
    }
   ]
  },
  "cmr": "us-cm-kg/NASDAQ/DRMA",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "ad_hoc": 1,
    "agm_egm": 3,
    "corporate_news": 5,
    "director_change": 3,
    "directors_dealings": 17,
    "halt_suspension": 1,
    "prospectus": 8,
    "regulatory_filing": 21,
    "results": 8
   },
   "cadence_median_gap_days": 5,
   "filing_days": 40,
   "filings": 67,
   "latency_days": 6,
   "latest": [
    {
     "category": "SCHEDULE 13G",
     "date": "2026-11-02",
     "source": "https://www.sec.gov/Archives/edgar/data/1853816/000092189526002901/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G",
     "type": "regulatory_filing"
    },
    {
     "category": "8-K",
     "date": "2026-10-29",
     "source": "https://www.sec.gov/Archives/edgar/data/1853816/000149315226049312/form8-k.htm",
     "title": "8-K — 8-K (items 8.01)",
     "type": "corporate_news"
    },
    {
     "category": "424B3",
     "date": "2026-10-21",
     "source": "https://www.sec.gov/Archives/edgar/data/1853816/000149315226047911/form424b3.htm",
     "title": "424B3 — 424B3",
     "type": "prospectus"
    },
    {
     "category": "EFFECT",
     "date": "2026-10-20",
     "source": "https://www.sec.gov/Archives/edgar/data/1853816/999999999526003304/xslEFFECTX01/primary_doc.xml",
     "title": "EFFECT (items ,,)",
     "type": "regulatory_filing"
    },
    {
     "category": "S-3",
     "date": "2026-10-09",
     "source": "https://www.sec.gov/Archives/edgar/data/1853816/000149315226046518/forms-3.htm",
     "title": "S-3 — S-3",
     "type": "prospectus"
    }
   ],
   "latest_filing_date": "2026-11-02",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/DRMA",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-09",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US2498455045"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001853816.json",
    "state": "sourced",
    "value": "United States — Delaware"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-DE",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001853816.json",
    "state": "sourced",
    "value": "Dermata Therapeutics, Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001853816.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001853816.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "DRMA"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [
    {
     "date": "2026-08-17",
     "source": "https://www.sec.gov/Archives/edgar/data/1853816/000135445726000799/xslF25X02/primary_doc.xml",
     "title": "25-NSE"
    }
   ],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:c6dd7a46fa0a61f74b253428b55b87c487eabe66c983bb6a049b67be4cb27895",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/DRMA",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:c6dd7a46fa0a61f74b253428b55b87c487eabe66c983bb6a049b67be4cb27895",
 "path": "/us/NASDAQ/DRMA",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Dermata Therapeutics, Inc., listed on NASDAQ under ticker DRMA, with ISIN US2498455045. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Security type is Corporate, sector is 2834 Pharmaceutical Preparations, and jurisdiction is United States, Delaware. Segment is not on the record. Status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 67 filings across 40 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 5 days, and the latest filing is 6 days before the record date of 2026-11-08. The latest filing is a regulatory filing dated 2026-11-02. Exchange peers on NASDAQ (4,359 issuers) show a median of 52 filings, a median cadence gap of 6.0 days, and a median latency of 5.0 days. Sector peers in 2834 Pharmaceutical Preparations (526 issuers) show a median of 63.0 filings, a median cadence gap of 6.0 days, and a median latency of 4.0 days. The issuer's filing count of 67 is above the exchange median of 52 and above the sector median of 63.0.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is CBIZ CPAs P.C, located in San Diego, California. The record holds one auditor change, dated 2026-02-03.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds one delisting line, dated 2026-08-17. No listing or name change lines are on the record. Domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). Segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001853816.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/DRMA"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1853816/000149315226012992/form10-k.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/DRMA"
  }
 ],
 "title": "Dermata Therapeutics, Inc. (DRMA) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}